In EOC, Inaba et al. showed that high IDO expression in the tumor cells correlated with a reduced number of CD8+ tumor-infiltrating lymphocytes (TILs) and that administration of an IDO inhibitor decreased the tumor peritoneal dissemination [26]. Here, CD8A is linked to neoplasm.